Pfizer and partner BioNTech agreed to supply an additional 100 million doses of their Covid-19 vaccine to the U.S., as the country seeks to widen its immunization program and revive its economy. From a report: The agreement brings the total number of doses to be delivered to the U.S. to 200 million, the companies said Wednesday in a statement. The drugmaker…